The management of systemic lupus erythematosus: Facts and controversies
- PMID: 20541688
- DOI: 10.1016/j.clindermatol.2009.06.017
The management of systemic lupus erythematosus: Facts and controversies
Abstract
Systemic lupus erythematosus is a multisystem disease of unknown etiology in which dysregulation of the innate and adaptive immune systems has a major effect in the pathogenesis of the disease. The treatment should be tailored for each patient according to how the disease manifests itself. Although there is no cure for systemic lupus erythematosus, the current treatment, using anti-inflammatory, antimalarial, and immunosuppressive agents, is fairly effective, but serious adverse events are possible. New biologic agents that target various components of the immune system recently have been developed for the treatment of patients with systemic lupus erythematosus.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Systemic lupus erythematosus IX: nonsteroidal anti-inflammatory drugs and antimalarial agents.Md State Med J. 1984 Apr;33(4):296-8. Md State Med J. 1984. PMID: 6727438 No abstract available.
-
The treatment of SLE: the case of conservative management.Clin Rheum Dis. 1982 Apr;8(1):299-313. Clin Rheum Dis. 1982. PMID: 6214364 Review. No abstract available.
-
Innovative management of lupus erythematosus.Dermatol Clin. 2010 Jul;28(3):489-99. doi: 10.1016/j.det.2010.03.007. Dermatol Clin. 2010. PMID: 20510759
-
Medical therapy for systemic lupus erythematosus.J Miss State Med Assoc. 2011 Feb;52(2):39-43. J Miss State Med Assoc. 2011. PMID: 21387869 Review.
-
[Development and long term prognosis of lupus erythematosus (apropos of 124 cases)].Ann Med Interne (Paris). 1977 Jan;128(1):17-30. Ann Med Interne (Paris). 1977. PMID: 855968 French.
Cited by
-
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006.Rheumatology (Oxford). 2014 Mar;53(3):502-11. doi: 10.1093/rheumatology/ket378. Epub 2013 Nov 22. Rheumatology (Oxford). 2014. PMID: 24273022 Free PMC article. Clinical Trial.
-
Systemic lupus erythematosus: pathogenesis and targeted therapy.Mol Biomed. 2024 Oct 30;5(1):54. doi: 10.1186/s43556-024-00217-8. Mol Biomed. 2024. PMID: 39472388 Free PMC article. Review.
-
Pragmatic approaches to therapy for systemic lupus erythematosus.Nat Rev Rheumatol. 2014 Feb;10(2):97-107. doi: 10.1038/nrrheum.2013.157. Epub 2013 Oct 29. Nat Rev Rheumatol. 2014. PMID: 24166241 Review.
-
Drug History and SLE Laboratory Findings Among Iraqi Patients: A Hospital-Based Study.Health Sci Rep. 2025 Mar 19;8(3):e70493. doi: 10.1002/hsr2.70493. eCollection 2025 Mar. Health Sci Rep. 2025. PMID: 40114752 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical